Breast cancer starts when cells in the breast begin to grow out of control. The cancers can start from different parts of the breast. It can start from the ducts that carry milk to the nipple or in the glands that make breast milk.
The U.S. Food and Drug Administration FDA has approved Nerlynx a once-daily oral tyrosine kinase inhibitor for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer.
Nerlynx is a prescription medicine used to treat adults who have early-stage breast cancer, which is HER2-positive and has previously been treated with the medicine trastuzumab.
Nerlynx may cause serious side effects like diarrhea, liver problems, fatigue,
vomiting, fever, rash, right upper abdominal pain, weight loss and urinary tract infection UTI.
Pregnant women, nursing mother and women planning to get pregnant can not use Nerlynx.
haleplushearty.blogspot.com
No comments:
Post a Comment